Have you or your loved ones been diagnosed with carcinoma, transitional cell?

You may be eligible to participate in a carcinoma, transitional cell clinical trial.

Have you or your loved ones been diagnosed with carcinoma, transitional cell? You may be eligible to participate in a carcinoma, transitional cell clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Carcinoma, Transitional Cell Clinical Trial in San Francisco CA
NCT02451423 | Phase 2 | Interventional
Lawrence Fong
Sponsored by
Lawrence Fong

Have you or your loved ones been diagnosed with carcinoma, transitional cell?

You may be eligible to participate in a carcinoma, transitional cell clinical trial.

Have you or your loved ones been diagnosed with carcinoma, transitional cell? You may be eligible to participate in a carcinoma, transitional cell clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 23 Participants

This phase II trial studies the best dose of atezolizumab in treating patients with bladder cancer that has not spread to other places in the body. Immunotherapy with monoclonal antibodies may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.